Table 1.
Average Age [Years] | Gender [% Females] | ||
---|---|---|---|
Stage 1 Single dose |
Cohort 1A | 30.9 | 16.7 |
Cohort 1B | 33.4 | 8.3 | |
Cohort 1C | 28.0 | 33.3 | |
Cohort 1D | 28.3 | 58.3 | |
Total | 30.2 | 29.2 | |
Stage 2 Multiple doses |
Cohort 2A | 32.3 | 41.7 |
Cohort 2B | 29.3 | 41.7 | |
Cohort 2C | 33.0 | 50.0 | |
Total | 31.6 | 44.4 | |
Stage 1 Single dose |
Placebo | 30.8 | 18.8 |
Vaccine | 29.8 | 34.4 | |
Total | 30.2 | 29.2 | |
Stage 2 Multiple doses |
Placebo | 33.3 | 41.7 |
Vaccine | 29.3 | 45.8 | |
Total | 31.6 | 44.4 |